Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction

J. Kračmerová, L. Rossmeislová, Z. Kováčová, E. Klimčáková, J. Polák, M. Tencerová, L. Mališová, V. Štich, D. Langin, M. Šiklová,

. 2014 ; 99 (3) : E528-E535.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky kontrolované, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074336

Grantová podpora
NT14486 MZ0 CEP - Centrální evidence projektů

CONTEXT: Soluble CD163 (sCD163) was suggested as a biomarker of insulin sensitivity and CD163 mRNA expression representing macrophage content in adipose tissue (AT). OBJECTIVE: The aim of this study was to investigate, in cross-sectional and prospective design, the relationship between sCD163 circulating levels and CD163 mRNA expression in adipose tissue and insulin sensitivity assessed by euglycemic-hyperinsulinemic clamp. DESIGN, SETTING, PARTICIPANTS, AND INTERVENTIONS: Two cohorts of subjects were examined in the study. Cohort 1 included 42 women with a wide range of body mass index (17-48 kg/m(2)); cohort 2 included 27 obese women who followed a dietary intervention consisting of 1 month of a very low-calorie diet and 5 months of a weight-stabilization period. MAIN OUTCOME MEASURES: Serum levels of CD163 and mRNA expression of CD163 and CD68 in sc and visceral (visc) AT were determined, and insulin sensitivity [expressed as glucose disposal rate (GDR)] was measured in cohort 1. In cohort 2, serum levels of CD163, mRNA expressions of CD163, CD68, and CD163-shedding factors [TNF-α-converting enzyme (TACE) and tissue inhibitor of metalloproteinase (TIMP3)] in sc AT were examined and GDR was measured before and during dietary intervention. RESULTS: In cohort 1, circulating sCD163 correlated with CD163 mRNA levels in both sc and visc AT. sCD163 and CD163 mRNA expression in both fat depots correlated with GDR. In cohort 2, the diet-induced changes of sCD163 levels did not correlate with those of CD163, CD68, TACE, and TIMP3 mRNA levels. Although the pattern of the diet-induced change of sCD163 paralleled that of GDR, there was no correlation between the changes of these two variables. CONCLUSION: sCD163 correlates with CD163 mRNA expression in sc and visc AT and with whole-body insulin sensitivity in the steady-state condition. These associations are not observed with respect to the diet-induced changes during a weight-reducing hypocaloric diet.

000      
00000naa a2200000 a 4500
001      
bmc14074336
003      
CZ-PrNML
005      
20200716132631.0
007      
ta
008      
141006s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jc.2013-3348 $2 doi
035    __
$a (PubMed)24423341
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kračmerová, Jana $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic; $7 xx0240527
245    10
$a Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction / $c J. Kračmerová, L. Rossmeislová, Z. Kováčová, E. Klimčáková, J. Polák, M. Tencerová, L. Mališová, V. Štich, D. Langin, M. Šiklová,
520    9_
$a CONTEXT: Soluble CD163 (sCD163) was suggested as a biomarker of insulin sensitivity and CD163 mRNA expression representing macrophage content in adipose tissue (AT). OBJECTIVE: The aim of this study was to investigate, in cross-sectional and prospective design, the relationship between sCD163 circulating levels and CD163 mRNA expression in adipose tissue and insulin sensitivity assessed by euglycemic-hyperinsulinemic clamp. DESIGN, SETTING, PARTICIPANTS, AND INTERVENTIONS: Two cohorts of subjects were examined in the study. Cohort 1 included 42 women with a wide range of body mass index (17-48 kg/m(2)); cohort 2 included 27 obese women who followed a dietary intervention consisting of 1 month of a very low-calorie diet and 5 months of a weight-stabilization period. MAIN OUTCOME MEASURES: Serum levels of CD163 and mRNA expression of CD163 and CD68 in sc and visceral (visc) AT were determined, and insulin sensitivity [expressed as glucose disposal rate (GDR)] was measured in cohort 1. In cohort 2, serum levels of CD163, mRNA expressions of CD163, CD68, and CD163-shedding factors [TNF-α-converting enzyme (TACE) and tissue inhibitor of metalloproteinase (TIMP3)] in sc AT were examined and GDR was measured before and during dietary intervention. RESULTS: In cohort 1, circulating sCD163 correlated with CD163 mRNA levels in both sc and visc AT. sCD163 and CD163 mRNA expression in both fat depots correlated with GDR. In cohort 2, the diet-induced changes of sCD163 levels did not correlate with those of CD163, CD68, TACE, and TIMP3 mRNA levels. Although the pattern of the diet-induced change of sCD163 paralleled that of GDR, there was no correlation between the changes of these two variables. CONCLUSION: sCD163 correlates with CD163 mRNA expression in sc and visc AT and with whole-body insulin sensitivity in the steady-state condition. These associations are not observed with respect to the diet-induced changes during a weight-reducing hypocaloric diet.
650    _2
$a tuková tkáň $x metabolismus $7 D000273
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a CD antigeny $x krev $x genetika $7 D015703
650    _2
$a antigeny diferenciační myelomonocytární $x krev $x genetika $7 D015214
650    12
$a kalorická restrikce $7 D031204
650    _2
$a kohortové studie $7 D015331
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykemický clamp $7 D015309
650    _2
$a lidé $7 D006801
650    _2
$a inzulinová rezistence $x genetika $7 D007333
650    _2
$a lidé středního věku $7 D008875
650    12
$a obezita $x dietoterapie $x genetika $x metabolismus $7 D009765
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a receptory buněčného povrchu $x krev $x genetika $7 D011956
650    _2
$a mladý dospělý $7 D055815
655    _2
$a klinické zkoušky kontrolované $7 D018848
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rossmeislová, Lenka $7 xx0095550 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Kováčová, Zuzana $7 xx0095549 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Klimčáková, Eva $7 xx0081734 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Polák, Jan $7 xx0102455
700    1_
$a Tencerová, Michaela $7 xx0240533 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Mališová, Lucia $7 xx0239427 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Štich, Vladimír, $d 1946- $7 xx0050390 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
700    1_
$a Langin, Dominique $7 xx0240532 $u INSERM, 31059 Toulouse, France; INSERM, Unité Mixte de Recherche 1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, 31432 Toulouse, France; University of Toulouse, Unité Mixte de Recherche 1048, Paul Sabatier University, 31432 Toulouse, France; and Department of Clinical Biochemistry, Toulouse University Hospitals, 31000 Toulouse, France
700    1_
$a Šiklová, Michaela $7 xx0187020 $u Department of Sport Medicine and Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague 100 00 Czech Republic
773    0_
$w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 99, č. 3 (2014), s. E528-E535
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24423341 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20200716132628 $b ABA008
999    __
$a ok $b bmc $g 1042219 $s 873248
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 99 $c 3 $d E528-E535 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
GRA    __
$a NT14486 $p MZ0
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...